Health Care

NERA's Global Health Care Practice covers the full range of litigation, regulatory/reform, public policy, and business strategy questions that arise in this complex industry. Our health economists have analyzed hundreds of mergers involving hospitals, health insurers, physicians, pharmaceuticals, and medical device companies. Many of these mergers have been reviewed by both US and European antitrust authorities. Our litigation experience covers antitrust issues such as monopolization, price fixing, unfair methods of competition, exclusive dealing, and other vertical restraints issues, such as those posed by integrated health care systems.

In the area of public policy, our economists in the US and Europe have worked with governments as well as purchasers and providers of health care around the world to create competitive markets, develop alternative administrative strategies, and enact realistic health care reforms that can improve both the efficiency and the fairness of health systems around the world. Our policy work has been used by organizations such as the European Commission, World Trade Organization, and US Trade Representatives to improve the environment for pharmaceutical research and development.

Name Title Location Phone Email
Dr. Lawrence Wu President San Francisco +1 415 291 1007
Dr. Graeme Hunter Managing Director New York City +1 212 345 7724
James Mellsop Managing Director
Chair of NERA's Global Antitrust and Competition Practice
+64 9 928 3290
+64 4 819 2550
+61 2 8864 6536
Dr. Subramaniam (Subbu) Ramanarayanan Managing Director New York City
Los Angeles
+1 212 345 0745
+1 213 346 3038
Dr. Ramsey Shehadeh Managing Director New York City +1 212 345 6089
Grant Saggers Director London +44 20 7659 8802
Dr. Paul Wong Director Los Angeles +1 213 346 3026
Dr. Alexandre Carbonnel Associate Director Paris
+33 1 70 75 01 60
+32 2 674 8815
Dr. Garrett Glasgow Associate Director San Francisco +1 415 291 1029
Dr. Emily Walden Senior Consultant Washington, DC +1 202 466 9220
Brigid Jung Consultant New York City +1 212 345 7039
Dr. Michael Baye Affiliated Academic Washington, DC +1 202 466 9298
Dr. Alyssa Lutz Affiliated Consultant Los Angeles +1 714 545 3000
Dr. Thomas McCarthy Affiliated Consultant Los Angeles +1 213 346 3000
Title Type Author
Non-Compete Agreements: Might They Be Procompetitive in Health Care? Published Article Dr. Paul Wong and Dr. Emily Walden
Drug Rebates: A Peek Behind the Curtain at Drug Prices Published Article Dr. Christopher Stomberg
Exclusive Dealing in Healthcare Published Article Dr. Emily Walden
Indiana Hospitals Do Not Have a "Monopoly Problem" Report Dr. Paul Wong
Taking Stock of the Efficiencies Defense: Lessons from Recent Health Care Merger Revi... Published Article Dr. Subramaniam Ramanarayanan
Expert Witnesses in Competition Disputes Published Article By Dr. David Blackburn, Nathan Blalock, Dr. Subbu Ramanarayanan, and Dr. Paul Wong
Testimony Before the United States House Committee on the Judiciary, Subcommittee on ... Testimony Dr. Lawrence Wu
Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... Published Article Bryan Ray and Dr. Subbu Ramanarayanan
Diversion Analysis as Applied to Hospital Mergers: A Primer Published Article By Dr. Subramaniam (Subbu) Ramanarayanan
A Profile of Professor Martin S. Gaynor (Director, FTC Bureau of Economics) Published Article By Dr. Subramaniam (Subbu) Ramanarayanan